Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00066157 · ClinicalTrials.gov registry record · Phase 2
Alzheimer's Disease: Therapeutic Potential of Estrogen
A Phase 2 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 2
- Development phase
- 42
- Enrollment target
NCT00066157 is a Phase 2 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 42 participants.
The verdict
NCT00066157, a Phase 2 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 42 participants
- Enrollment target
Study Summary
This is a 15-month study to determine the effectiveness of hormone replacement therapy in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease.
Interventions
- DRUG Placebo
- DRUG Placebo Patch
- DRUG Transdermal estradiol
- DRUG Medroxyprogesterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2001-09 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00066157
The ClinicalTrials.gov registry entry for NCT00066157 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00066157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00066157 about?
NCT00066157 is a clinical study titled "Alzheimer's Disease: Therapeutic Potential of Estrogen". This is a 15-month study to determine the effectiveness of hormone replacement therapy in improving memory and the ability to live independently in postmenopausal women with Alzheimer's disease.
What is the current status of trial NCT00066157?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 42 participants. The study started on 2001-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00066157?
The interventions under investigation include: Placebo (DRUG), Placebo Patch (DRUG), Transdermal estradiol (DRUG), Medroxyprogesterone (DRUG).
Who is sponsoring clinical trial NCT00066157?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.